Optimising Secondary Prevention and Cardiac Rehabilitation for Atherosclerotic Cardiovascular Disease During the COVID-19 Pandemic: A Position Statement From the Cardiac Society of Australia and New Zealand (CSANZ).

Nicholls, SJ; Nelson, M; Astley, C; Briffa, T; Brown, A; Clark, R; Colquhoun, D; Gallagher, R; Hare, DL; Inglis, S; Jelinek, M; O'Neil, A; Tirimacco, R; Vale, M; Redfern, J

Optimising Secondary Prevention and Cardiac Rehabilitation for Atherosclerotic Cardiovascular Disease During the COVID-19 Pandemic: A Position Statement From the Cardiac Society of Australia and New Zealand (CSANZ).

Nicholls, SJ Nelson, M Astley, C Briffa, T Brown, A Clark, R Colquhoun, D Gallagher, R Hare, DL Inglis, S

Jelinek, M O'Neil, A Tirimacco, R Vale, M Redfern, J

Permalink

Publisher:: ELSEVIER SCIENCE INC
Publication Type:: Journal Article
Citation:: Heart, lung & circulation, 2020, 29, (7), pp. e99-e104
Issue Date:: 2020-07

Closed Access

	Filename	Description	Size
	Optimising Secondary Prevention and Cardiac Rehabilitation for Atherosclerotic Cardiovascular Disease During the COVID-19 Pa.pdf		309.11 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Nicholls, SJ
dc.contributor.author	Nelson, M
dc.contributor.author	Astley, C
dc.contributor.author	Briffa, T
dc.contributor.author	Brown, A
dc.contributor.author	Clark, R
dc.contributor.author	Colquhoun, D
dc.contributor.author	Gallagher, R
dc.contributor.author	Hare, DL
dc.contributor.author	Inglis, S https://orcid.org/0000-0002-1331-5912
dc.contributor.author	Jelinek, M
dc.contributor.author	O'Neil, A
dc.contributor.author	Tirimacco, R
dc.contributor.author	Vale, M
dc.contributor.author	Redfern, J
dc.date.accessioned	2021-06-22T04:00:53Z
dc.date.available	2021-06-22T04:00:53Z
dc.date.issued	2020-07
dc.identifier.citation	Heart, lung & circulation, 2020, 29, (7), pp. e99-e104
dc.identifier.issn	1443-9506
dc.identifier.issn	1444-2892
dc.identifier.uri	http://hdl.handle.net/10453/149708
dc.description.abstract	<h4>Background</h4>The coronavirus disease 2019 (COVID-19) pandemic has introduced a major disruption to the delivery of routine health care across the world. This provides challenges for the use of secondary prevention measures in patients with established atherosclerotic cardiovascular disease (CVD). The aim of this Position Statement is to review the implications for effective delivery of secondary prevention strategies during the COVID-19 pandemic.<h4>Challenges</h4>The COVID-19 pandemic has introduced limitations for many patients to access standard health services such as visits to health care professionals, medications, imaging and blood tests as well as attendance at cardiac rehabilitation. In addition, the pandemic is having an impact on lifestyle habits and mental health. Taken together, this has the potential to adversely impact the ability of practitioners and patients to adhere to treatment guidelines for the prevention of recurrent cardiovascular events.<h4>Recommendations</h4>Every effort should be made to deliver safe, ongoing access to health care professionals and the use of evidenced based therapies in individuals with CVD. An increase in use of a range of electronic health platforms has the potential to transform secondary prevention. Integrating research programs that evaluate the utility of these approaches may provide important insights into how to develop more optimal approaches to secondary prevention beyond the pandemic.
dc.format	Print-Electronic
dc.language	eng
dc.publisher	ELSEVIER SCIENCE INC
dc.relation.ispartof	Heart, lung & circulation
dc.relation.isbasedon	10.1016/j.hlc.2020.04.007
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	1102 Cardiorespiratory Medicine and Haematology, 1117 Public Health and Health Services
dc.subject.classification	Cardiovascular System & Hematology
dc.subject.mesh	Humans
dc.subject.mesh	Pneumonia, Viral
dc.subject.mesh	Coronavirus Infections
dc.subject.mesh	Cardiovascular Diseases
dc.subject.mesh	Consensus
dc.subject.mesh	Cardiology
dc.subject.mesh	Infection Control
dc.subject.mesh	Societies, Medical
dc.subject.mesh	Delivery of Health Care
dc.subject.mesh	Australia
dc.subject.mesh	New Zealand
dc.subject.mesh	Secondary Prevention
dc.subject.mesh	Pandemics
dc.subject.mesh	Cardiac Rehabilitation
dc.subject.mesh	Betacoronavirus
dc.subject.mesh	COVID-19
dc.subject.mesh	SARS-CoV-2
dc.subject.mesh	Australia
dc.subject.mesh	Betacoronavirus
dc.subject.mesh	COVID-19
dc.subject.mesh	Cardiac Rehabilitation
dc.subject.mesh	Cardiology
dc.subject.mesh	Cardiovascular Diseases
dc.subject.mesh	Consensus
dc.subject.mesh	Coronavirus Infections
dc.subject.mesh	Delivery of Health Care
dc.subject.mesh	Humans
dc.subject.mesh	Infection Control
dc.subject.mesh	New Zealand
dc.subject.mesh	Pandemics
dc.subject.mesh	Pneumonia, Viral
dc.subject.mesh	SARS-CoV-2
dc.subject.mesh	Secondary Prevention
dc.subject.mesh	Societies, Medical
dc.title	Optimising Secondary Prevention and Cardiac Rehabilitation for Atherosclerotic Cardiovascular Disease During the COVID-19 Pandemic: A Position Statement From the Cardiac Society of Australia and New Zealand (CSANZ).
dc.type	Journal Article
utslib.citation.volume	29
utslib.location.activity	Australia
utslib.for	1102 Cardiorespiratory Medicine and Haematology
utslib.for	1117 Public Health and Health Services
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/IMPACCT
utslib.copyright.status	closed_access	*
dc.date.updated	2021-06-22T04:00:52Z
pubs.issue	7
pubs.publication-status	Published
pubs.volume	29
utslib.citation.issue	7

Abstract:

Background

The coronavirus disease 2019 (COVID-19) pandemic has introduced a major disruption to the delivery of routine health care across the world. This provides challenges for the use of secondary prevention measures in patients with established atherosclerotic cardiovascular disease (CVD). The aim of this Position Statement is to review the implications for effective delivery of secondary prevention strategies during the COVID-19 pandemic.

Challenges

The COVID-19 pandemic has introduced limitations for many patients to access standard health services such as visits to health care professionals, medications, imaging and blood tests as well as attendance at cardiac rehabilitation. In addition, the pandemic is having an impact on lifestyle habits and mental health. Taken together, this has the potential to adversely impact the ability of practitioners and patients to adhere to treatment guidelines for the prevention of recurrent cardiovascular events.

Recommendations

Every effort should be made to deliver safe, ongoing access to health care professionals and the use of evidenced based therapies in individuals with CVD. An increase in use of a range of electronic health platforms has the potential to transform secondary prevention. Integrating research programs that evaluate the utility of these approaches may provide important insights into how to develop more optimal approaches to secondary prevention beyond the pandemic.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/149708